Case report: Germline BRCA 2 mutation in primary peritoneal carcinoma: a rare malignancy
The patient was treated with the BRCA-targeting agents and had a good prognosis after surgery.
Authors
- Yanying Huang (ORCID: https://orcid.org/0000-0003-3141-7936)
- Wenjun Xie (ORCID: https://orcid.org/0000-0003-0493-062X)
- Yue Zhang (ORCID: https://orcid.org/0000-0002-6612-8002)
- Zhaodong Li (ORCID: https://orcid.org/0000-0001-7552-4392)
Institutions
- Hangzhou Hospital of Traditional Chinese Medicine (CN)
- Hangzhou Red Cross Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-09-03
- DOI
- https://doi.org/10.3389/fonc.2024.1428918
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00